STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting

1d ago, source:

Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac ...

Cytosorbents Corporation (NASDAQ:CTSO) Q4 2023 Earnings Call Transcript

1mon ago, source: InvestingChannel on MSN

Cytosorbents Corporation (NASDAQ:CTSO) Q4 2023 Earnings Call Transcript March 14, 2024 Cytosorbents Corporation isn't one of ...

CytoSorbents Reports Fourth Quarter and Full Year 2023 Results

1mon ago, source: Business Insider

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary ...

CytoSorbents Corp HQE1

25d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Cytosorbents Corporation (CTSO)

1mon ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

CytoSorbents Reports First Quarter 2023 Results

17d ago, source: ADVFN

PRINCETON, N.J., May 02, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...

These Analysts Think Cytosorbents Corporation's (NASDAQ:CTSO) Sales Are Under Threat

29d ago, source: Yahoo Finance

The analysts covering Cytosorbents Corporation (NASDAQ:CTSO) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for this year. There ...

CytoSorbents Reports Fourth Quarter and Full Year 2023 Results

1mon ago, source: Stockhouse

CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer ...

Cytosorbents Corp.

22d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Cytosorbents Corp

28d ago, source: U.S. News & World Report

Analysts say these cheap stocks have plenty of upside.